2 Libby P, Ridker P M, Hansson G K. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, 473: 317-325
[2]
3 Collins R G, Velji R, Guevara N V, et al. P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med, 2000, 191: 189-194
[3]
4 Poston R N, Haskard D O, Coucher J R, et al. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol, 1992, 140: 665-673
[4]
5 Myers C L, Desai S N, Schembri-King J, et al. Discriminatory effects of protein kinase inhibitors and calcium ionophore on endothelial ICAM-1 induction. Am J Physiol, 1992, 262: C365-C373
[5]
6 Kim I, Moon S O, Kim S H, et al. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem, 2001, 276: 7614-7620
[6]
7 Xue J, Thippegowda P B, Hu G, et al. NF-kappaB regulates thrombin-induced ICAM-1 gene expression in cooperation with NFAT by binding to the intronic NF-kappaB site in the ICAM-1 gene. Physiol Genomics, 2009, 38: 42-53
[7]
8 Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem, 2004, 73: 417-435
[8]
9 Cho K W, Lumeng C N. SirT1: a guardian at the gates of adipose tissue inflammation. Diabetes, 2011, 60: 3100-3102
[9]
20 Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol, 1991, 147: 2777-2786
[10]
21 Ledebur H C, Parks T P. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-kappa B site and p65 homodimers. J Biol Chem, 1995, 270: 933-943
[11]
22 Potente M, Dimmeler S. Emerging roles of SIRT 1 in vascular endothelial homeostasis. Cell Cycle, 2008, 7: 2117-2122
[12]
23 Zhang H N, Li L, Gao P, et al. Involvement of the p65/RelA subunit of NF-kappaB in TNF-alpha-induced SIRT1 expression in vascular smooth muscle cells. Biochem Biophys Res Commun, 2010, 397: 569-575
[13]
24 Yang C M, Luo S F, Hsieh H L, et al. Interleukin-1beta induces ICAM-1 expression enhancing leukocyte adhesion in human rheumatoid arthritis synovial fibroblasts: involvement of ERK, JNK, AP-1, and NF-kappaB. J Cell Physiol, 2010, 224: 516-526
[14]
1 Libby P. Inflammation in atherosclerosis. Nature, 2002, 420: 868-874
[15]
10 Yoshizaki T, Schenk S, Imamura T, et al. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am J Physiol Endocrinol Metab, 2010, 298: E419-E428
[16]
11 Planavila A, Iglesias R, Giralt M, et al. Sirt1 acts in association with PPARalpha to protect the heart from hypertrophy, metabolic dysregulation, and inflammation. Cardiovasc Res, 2011, 90: 276-284
[17]
12 Yeung F, Hoberg J E, Ramsey C S, et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. Embo J, 2004, 23: 2369-2380
[18]
13 Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127: 1109-1122
[19]
14 Li X, Zhang S, Blander G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell, 2007, 28: 91-106
[20]
15 Zhang R, Chen H Z, Liu J J, et al. SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages. J Biol Chem, 2010, 285: 7097-7110
[21]
16 Zhang Q J, Wang Z, Chen H Z, et al. Endothelium-specific overexpression of class Ⅲ deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res, 2008, 80: 191-199
[22]
17 Stein S, Schafer N, Breitenstein A, et al. SIRT1 reduces endothelial activation without affecting vascular function in ApoE-/- mice. Aging, 2010, 2: 353-360
[23]
18 Takata T, Ishikawa F. Human Sir2-related protein SIRT1 associates with the bHLH repressors HES1 and HEY2 and is involved in HES1- and HEY2-mediated transcriptional repression. Biochem Biophys Res Commun, 2003, 301: 250-257
[24]
19 Zhou S, Chen H Z, Wan Y Z, et al. Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction. Circ Res, 2011, 109: 639-648
